Skip to content

Effectiveness and Cost-effectiveness of a Telemonitoring Program for Diabetic People at Home

Effectiveness and Cost-effectiveness Analysis of a Telemonitoring Program on Lifestyle for People With Type 2 Diabetes at Home. Study Based on a Health Network in Diabetology.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01955031
Acronym
EDUC@DOM
Enrollment
282
Registered
2013-10-07
Start date
2013-11-30
Completion date
2019-07-31
Last updated
2021-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

Telemedicine, Telemonitoring, Education, Nutrition, Food behaviour, Weight, Physical activity, Glycaemia, Self-monitoring blood glucose

Brief summary

Severity of diabetes is related to the development of disabling and costly complications (12.9 billion euros in 2007). The French High Health Authority recommends a therapeutic education on lifestyle and dietary rules in first-line treatment of Type 2 Diabetes Mellitus. Despite these recommendations, patients often have difficulties to implement dietary recommendations every day. The objective of EDUC@DOM is to help people with diabetes to improve lifestyle and equilibrium of glycaemia in order to avoid or delay chronic complications of diabetes. Our main goal is to assess effectiveness of our telemonitoring program in type 2 patients' care compared to a usual care of diabetes, on the glycaemia of the patients. It is expected that our program leads to a better monitoring of health status, a greater adherence to medical and non-medical prescriptions, an empowerment of the patient, and as a consequence, a more efficient health care consumption.

Interventions

OTHERtelemonitoring

A telemonitoring program with educational tools is given to people with type 2 diabetes at their home. It is composed of three softwares to improve eating habits available on touchpad, a self-monitoring blood glucose device, a balance to measure weight and fat mass, and a pedometer to evaluate physical activity. Data are securely sent and stored into a web service which delivers a synthesis to patients and health professionals.

OTHERUsual care

Patients are recruited during therapeutic educational sessions or appointments by general practitioners or diabetologists who take part into the Regional Health Network in Diabetes DIAMIP. If patients accept to participate to the study and sign up the protocol consent, they are given questionnaires about nutrition, physical activity and quality of life. A dietician analyses with each patient the results of a food inquiry. Patients are randomised into two groups: one arm is trained to the telemonitoring program before receiving it at home, and the other arm follows usual care. During 12 months, the telemonitoring group uses the device. The investigators (GP or diabetologists) can use the specific secured website to follow the measured parameters and to make appropriate decisions about health care of their patient. No consultation are scheduled in advance.

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with type 2 diabetes * Older than 18 years * With an insulin treatment or not * Having a glycemic impairment characterized by 6.5% \<HbA1c ≤10 * Having an active internet connection at home. * Accepting the terms of training, loan and use of the device * Benefiting from social protection system * Having given his/her free and informed consent and signed the consent

Exclusion criteria

* Serious illness recently (\<3 months) or decompensated may influence glycemic control of the patient permanently according to the judgment of the physician in charge of monitoring * Retinal state that does not allow optimization in equilibrium of glycaemia * Known severe renal impairment defined by creatinine clearance \<30ml/min * Known hemoglobinopathy * Visual or intellectual resulting inability to use the remote monitoring tool according to the judgment of the physician in charge of monitoring * Inability to understand all or part of the software information according to the judgment of the physician in charge of monitoring * Subject to disabled * Person with severe behavioral disorders (anorexia, bulimia, ...) according to the judgment of the physician in charge of monitoring * Person who had, or in preparation for bariatric surgery (software nutrition education are not suitable for this type of care.) * Person with a medical device implanted electronic pacemakers and defibrillators with cardiac (possibility of interference with the impedance) * Another person involved in research including a period of ongoing exclusion to inclusion, * A person under legal protection * Subject living in institutions * Desire for pregnancy, pregnancy or breastfeeding

Design outcomes

Primary

MeasureTime frame
To assess effectiveness of our telemonitoring program in Diabetes care, HbA1C assays will be compared between the two groups.The change of HbA1c between day 0, month 1,month 3, month 6, month 9 and month 12HbA1c will be measured at Day 0, month 1, month 3, month 6, month 9 and month 12

Secondary

MeasureTime frame
For the telemonitoring arm, acceptability and satisfaction of the telemonitoring system by the health professionals with the number and time of connectionsAt month 24
Assessment efficacy of our program by the measure of HbA1C willAt month 15, month 18, month 21 and month 24
Questionnaires will be given to patients to assess the improvement of nutritional knowledgeAt day 0 and month 24
Food inquiries will be given to patients to assess the improvement of eating habitsAt day 0 and month 24
Questionnaires will be given to patients to assess the physical activity practiceAt day 0 and month 24
Waist circumference will be measured to assess the body composition, BMI (Body Mass Index),At day 0 and month 24
The self-monitoring blood glucose books will be copied to assess mean of blood glycaemiaAt day 0, month 12 and month 24
A blood sample will be collected to assess lipid statusAt day 0 and month 24
Two questionnaires will be given to patients to assess quality of life of patientsAt day 0 and month 24
A cost-effectiveness ratio and a markov modelisation will be realized to assess the economic aspectsAt month 24
For the telemonitoring arm, assessment of food behavior through meals registered with the Nutri-Educ softwareEverytime patients use the software from Day 0 to month 24
For the telemonitoring arm, assessment of nutritional knowledge through rate of good choices playing games of Nutri-Kiosk softwareEverytime patients use the software from Day0 to month 24
For the telemonitoring arm, assessment of physical activity declared through Acti-Kiosk software and measures collected with the pedometer (number of steps, number of stairs climbed up)Every time patients use the software and the pedometer from day 0 to month 24
For the telemonitoring arm, measure of weight, fat rate and lean rate collected with the balanceEverytime patients use the balance from day 0 to month 24
For the telemonitoring arm, means of glycaemia collected with the self-monitoring blood glucose deviceEverytime patients use the blood glucose device from day 0 to month 24
For the telemonitoring arm, acceptability and satisfaction of the telemonitoring system by the patients with the number and time of connections and a questionnaireAt month 24
For the telemonitoring arm, acceptability and satisfaction of the telemonitoring system by the health professionals with the number and time of connections leading to a medical decision (phone call or medical appointment) and a questionnaireAt month 24

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026